NDC 49702-221-44
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49702-221
- Requested NDC
- 49702-221-44
- Package NDCs from labels
- 49702-221-44
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49702-221-18 | EA - Each | 49702-221 | eb8a1321-bf1b-4e34-9e70-4215597755cb | 1 | 2012-07-24 |
| 49702-221-44 | EA - Each | 49702-221 | 9ac7422e-d48f-4550-bc93-676299ccbab1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tivicay | DOLUTEGRAVIR SODIUM | ViiV Healthcare Company | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 2026-08-25 | Warnings, Adverse reactions | ViiV Healthcare Company |
| Abacavir Sulfate | ABACAVIR SULFATE | Safecor Health, LLC | f7633480-25aa-4326-bec9-82835b486a20 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | ABACAVIR SULFATE |
| Cabenuva | CABOTEGRAVIR AND RILPIVIRINE | ViiV Healthcare Company | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 2025-11-26 | Warnings, Adverse reactions | ViiV Healthcare Company |
| Juluca | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | ViiV Healthcare Company | 806653d1-bf35-4924-b999-ad5d21821cc1 | 2025-10-29 | Warnings, Adverse reactions | ViiV Healthcare Company |
| Dovato | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | ViiV Healthcare Company | 68e45422-43ed-4cfb-9356-fae88d14a53a | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| Abacavir Sulfate | ABACAVIR SULFATE | Mylan Institutional Inc. | 80c1702a-973c-436a-90f8-69b29674dca0 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | ABACAVIR SULFATE |
| Vocabria | CABOTEGRAVIR SODIUM | ViiV Healthcare Company | 66d450fb-cca4-476c-b0c7-c0730e3e4cf3 | 2025-04-11 | Warnings, Adverse reactions | ViiV Healthcare Company |
| Apretude | CABOTEGRAVIR | ViiV Healthcare Company | 4338428e-43d4-4e02-ac9d-bd98e738a7da | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| Abacavir | ABACAVIR SULFATE | Rising Pharma Holdings, Inc. | ec9e2c36-b9b7-4ac2-a366-f3ad51237f28 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | ABACAVIR SULFATE |
| RETROVIR | ZIDOVUDINE | ViiV Healthcare Company | 6df09f15-b102-431c-adde-d7aeef6f5d84 | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| EPIVIR | LAMIVUDINE | ViiV Healthcare Company | 89226149-47fa-4f7d-bb1f-1aa7034486b8 | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| Triumeq | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | ViiV Healthcare Company | 2997739a-aa91-42aa-a206-a70e2db7b84f | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| Abacavir | ABACAVIR SULFATE | Aurobindo Pharma Limited | e2214976-657c-4018-b059-1ad66a7e2b6f | 2024-05-08 | Boxed warning, Warnings, Adverse reactions | ABACAVIR SULFATE |
| Rukobia | FOSTEMSAVIR TROMETHAMINE | ViiV Healthcare Company | a21006b7-6d6f-4f06-81b4-17978756452b | 2024-02-13 | Warnings, Adverse reactions | ViiV Healthcare Company |
| ZIAGEN | ABACAVIR SULFATE | ViiV Healthcare Company | ca73b519-015a-436d-aa3c-af53492825a1 | 2023-09-29 | Boxed warning, Warnings, Adverse reactions | ZIAGEN ABACAVIR SULFATE ViiV Healthcare Company |
| COMBIVIR | LAMIVUDINE AND ZIDOVUDINE | ViiV Healthcare Company | 16da660b-9981-4d24-a14a-94c7744fce4f | 2023-08-22 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| SELZENTRY | MARAVIROC | ViiV Healthcare Company | 46f30ac5-c96b-429e-976d-8c5ee1c0761b | 2022-09-26 | Boxed warning, Warnings, Adverse reactions | ViiV Healthcare Company |
| Abacavir Sulfate | ABACAVIR SULFATE | Mylan Pharmaceuticals Inc. | 5676d391-f9a4-44be-9604-954b3d8d0e2b | 2021-01-08 | Boxed warning, Warnings, Adverse reactions | ABACAVIR SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.